VTE & VTE/COVID-19 Resources

North American Thrombosis Forum (NATF)

The North American Thrombosis Forum is dedicated to saving lives through education and prevention. A major part of this is helping healthcare professionals stay up-to-date on the latest research in the rapidly changing field of thrombosis. Through educational events and informative articles geared specifically towards clinicians, NATF provides clinicians with the information they need to best treat their patients. Topics covered include thrombosis, stroke prevention, atrial fibrillation, diabetes, cardiovascular-related illnesses, and more. Check back regularly for important updates on everything from the development of new medications, to the release of novel research.

Managing Acute Respiratory Failure in Small, Rural, and Critical Access Hospitals: Non-Invasive Ventilation & High-Flow Nasal Cannula

This material was developed by IPRO HQIC.

Due to medical-surgical nurses’ limited exposure to managing acute respiratory failure, nurses in rural and critical access hospitals do not always have a comfort level with non-invasive ventilation (NIV) equipment and/or High-Flow Nasal Cannula (HFNC). Managing this situation on medical-surgical floors within these smaller hospitals created a void, especially without access to specialty staff who have advanced clinical respiratory experience, lack of critical care beds, and/or the lack of respiratory therapy resources. This is especially true in rural and critical access hospitals, possibly exacerbating adverse events and potentially increasing health disparities (due to access of specialty care issues). This electronic tool provides digestible information to support the front-line in CPAP, BiPAP, and HFNC management.

COVID-19 Frequently Asked Questions, In Plain Language

American Institutes for Research (AIR)

AIR has created a plain-language FAQ document that addresses a variety of topics related to the COVID-19 pandemic. Questions were drawn from numerous reliable government sources. The document was developed as a resource for schools, day cares, healthcare organizations, and other public centers to distribute. It is designed to make this information accessible and comprehensible to everyone, regardless of education level or background. Available in English, Spanish, Chinese.

How Patient and Family Advisory Councils Can Help Hospitals and Their Communities During the COVID-19 Pandemic

American Institutes for Research (AIR)/IPRO HQIC

COVID-19 is a perfect issue for PFACs to address. The experiences of patients and families can have a direct impact on how the hospital safely treats those with severe cases including those in isolation, prevents the spread of the virus, and minimizes the impact of the virus on health care and health outcomes (e.g., delayed care). This resource provides suggestions about how PFACs can help hospitals proactively communicate, educate, and engage with patients and families and the larger community to build trust and deliver high-quality care during a time of uncertainty and fear.

All-Cause Harm Resource

This resource explains what All-Cause Harm is, why it is important and then dives into each of the processes it takes to prevent All-Cause Harm. Eight priority focus areas for the Hospital Quality Improvement Contract (HQIC) are illuminated and strategies to monitor compliance are provided.

All-Cause Harm Resource, Recording and Slides from the IPRO HQIC All-Cause Harm “launch” on March 29th, 2021.

Conversation Guide to Improve COVID-19 Vaccine Uptake

IHI – Institute for Healthcare Improvement

This guide is intended to help health care staff and leaders have trust-building conversations about the COVID-19 vaccine, both at work and at home. Exploring people’s feelings about the vaccine through respectful, trust-building interactions over time offers the potential to increase the uptake of vaccinations. The guide helps health care staff and leaders begin to quickly engage in effective conversations about COVID-19 vaccination, enabling learning in practice and resolving issues that arise from such conversations. The focus is on having rich conversations to listen and learn about reasons and feelings for not getting vaccinated — and then seeking to have a dialogue about questions and concerns so that people can consider COVID-19 vaccination.

NUTRITION & IMMUNITY PODCAST SERIES: Pressure Injury

Abbott Nutrition Health Institute (ANHI)

Panel of world-renowned experts discuss nutrition guidelines for caring for COVID-19 patients.

  • NUTRITION CARE FOR PRESSURE INJURIES: GUIDELINES TO OPTIMIZE OUTCOMES
  • THE ROLE OF HYDRATION IN ACUTE INFLAMMATORY PROCESS & RECOVERY
  • NATIONAL BLUEPRINT: ACHIEVING QUALITY MALNUTRITION CARE FOR OLDER ADULTS, 2020 UPDATE
  • NUTRITION SUPPORT OF THE COVID-19 ICU PATIENT
  • A REVIEW OF THE SCCM/ASPEN COVID-19 RECOMMENDATIONS
  • NUTRITIONAL NEEDS OF COVID-19 PATIENTS IN-HOSPITAL & POST-DISCHARGE

National Healthcare Safety Network (NHSN); Patient Safety Component Manual

CDC, National Healthcare Safety Network (NHSN)

The Patient Safety Component includes five modules that focus on events associated with medical devices, surgical procedures, antimicrobial agents used during healthcare, multidrug resistant organisms, and Coronavirus Infectious Disease 2019 (COVID-19).

Unavoidable Pressure Injury during COVID-19 Pandemic: A Position Paper from the National Pressure Injury Advisory Panel

National Pressure Injury Advisory Panel (NPIAP)

The purposes of this National Pressure Injury Advisory Panel (NPIAP) Position Paper are to:

  1. Summarize the current NPIAP position regarding unavoidable pressure injuries.
  2. Examine the effects of the COVID-19 crisis on the scope of what is considered an unavoidable pressure injury.
  3. State the position of the NPIAP regarding determinations of unavoidable pressure injuries during the COVID-19 crisis.
  4. Renew the NPIAP call to collaborate on the development of criteria for the determination of unavoidable pressure injuries in acute care.

Skin Manifestations with COVID-19

National Pressure Injury Advisory Panel (NPAIP)

Many reports are occurring concerning areas of purpuric/purple skin and purple toe lesions in patients diagnosed with COVID-19 (SARS-CoV-2). Wound care providers are being asked if these skin lesions are forms of Deep Tissue Pressure Injury and/or “skin failure”. Early reports of COVID-19 related
skin changes included rashes, acral areas of erythema with vesicles or pustules (pseudo-chilblain), other vesicular eruptions, urticarial lesions, maculopapular eruptions, and livedo or necrosis. The pattern and presentation of skin manifestations with COVID-19 is more than rashes. The purpose of this paper is to guide the wound care clinician in determining if the “purple skin” being seen is a deep tissue pressure injury or a cutaneous manifestation of COVID-19.